Healing at the speed of light™
The use of Low Level Laser Therapy (LLLT) as an alternative and/or as adjunct to conventional medical treatments, has significantly gained acceptance amongst healthcare practitioners in recent years. The technology has proven to add value to practitioners’ businesses and patients are very satisfied with results achieved. It is extensively utilized in Canada and the US. LLLT now forms a part of most if not all physiotherapy undergraduate training programs within the UK, and it is increasingly rare to find hospital physiotherapy departments or private clinics without access to this modality1.
Theralase Technologies Inc. (TSXV : TLT & OTC BB : TLTFF) designs, develops and manufactures patented, super-pulsed laser technology used in a wide range of bio-stimulation and bio-destruction clinical applications. The Theralase technology platform targets several diverse healthcare sectors firstly, for non-invasive pain management and clinical therapy, in hundreds of neural muscular skeletal conditions, (including arthritis) secondly, to bio-stimulate and accelerate wound care and healing, (including; bone fracture regeneration and osteoarthritic conditions) and thirdly, combining photodynamic compounds with super-pulsed, biofeedback laser technology to attack specifically targeted cancers, bacterium, viruses and fat cells.
The overriding competitive advantage of the Theralase laser technology is based on its more effective, deeper sub-dermal penetration capabilities. The primary and critical economic advantage of Theralase equipment for healthcare practitioners is that its NHN rating qualifies its units for several multiples of medical insurance reimbursement than that accorded to the limited ILY units.
This website portrays comprehensive information about Theralase’s technology, management, advisory board, and board of directors. For further inquiries or to request an investor kit, please contact Theralase at 1-866-THE-LASE, our highly trained staff is always eager to help.
1Baxter, David: Therapeutic Lasers Theory and Practice, Elsevier Health Sciences.